Actualités sur Enterprises

Shell Eco-marathon

Electrifying Times at the Shell Eco-marathon Europe With Debut of E-mobility Demonstration run

Lausitz, Germany, May 5, 2010 (ots/PRNewswire) - - 06-07 May Event at EuroSpeedway Lausitz, Germany Will See Introduction of E-mobility Demonstration run; First Step to Possible Introduction of new E-mobility Category at Future Editions - 17 Teams Scheduled to Participate - In Total, 213 Teams From 22 European Nations and Beyond are Under ...

Royal dutch shell plc

Shell Singapore: Meeting Asia's Growing Demand for Petrochemicals

The Hague, The Netherlands, May 4, 2010 (ots/PRNewswire) - Shell's largest integrated refinery and petrochemicals complex is now fully online. The multi-billion dollar project in Singapore boosts the supply of raw materials for many everyday products and uses ultra-efficient Shell technology. The site is already supplying products to Asian growth markets and to manufacturers in Singapore. It is a cornerstone of ...

Wyplay

WYPLAY Secures 9 Million Euro Third Round Financing

Marseille, France, May 4, 2010 (ots/PRNewswire) - WYPLAY SAS, a pioneer in the development of the High-Definition Media Center, today announced it has closed a 9 million euro third round of financing. Amundi Private Equity Funds, who led this 3rd round, was joined by A Plus Finance, Elaia Partners and Sofinnova Partners, Wyplay's second round lead investors reflecting their continued confidence in the company. ...

EvaluatePharma Ltd

Pfizer Reigns Supreme After Patent Cliff as Humira Kicks Avastin off Top Spot

London, May 3, 2010 (ots/PRNewswire) - The rheumatoid arthritis treatment Humira will replace Lipitor as the world's biggest-selling drug in 2016, but a familiar name, Pfizer, will still be the biggest seller of medicines after the patent cliff according to the World Preview 2016 report published today by EvaluatePharma, the premier provider of pharma and biotech ...

Celtic Pharmaceutical Holdings L.P.

Celtic Pharma Announces Initiation of Phase III Trial of TDT 067 for the Treatment of Onychomycosis

London, New York and Hamilton, Bermuda, April 30, 2010 (ots/PRNewswire) -- Celtic Pharmaceutical Holdings L.P. ("Celtic Pharma"), the global private equity firm focused on the biotechnology and pharmaceutical industries, announced today the enrolment of the first patient into its Phase III trial of TDT 067, terbinafine in Transfersomes(R), for the topical treatment ...

Agendia B.V.

New Study Demonstrates Patients With High-Risk MammaPrint Profile Benefit From Chemotherapy

HUNTINGTON BEACH, California, and AMSTERDAM, April 29, 2010 (ots/PRNewswire) -- Today, at the 11th Annual Meeting of the American Society of Breast Surgeons, Agendia, a world leader in molecular cancer diagnostics, announced that Breast Cancer Research and Treatment has published an important study demonstrating the benefit of adjuvant chemotherapy for patients with ...

Aon Consulting EMEA

European Workers Would Trade Money for an Early Retirement

Rotterdam, The Netherlands, April 29, 2010 (ots/PRNewswire) - The lure of retirement is simply too much for many Europeans with almost one in three workers (29%) saying they would prefer their government not to raise the national retirement age, and would be happy to have less income in retirement, according to Aon Consulting, the leading employee risk and benefits management firm. This research is part of the Aon ...

Kowa Company, Ltd.

Pitavastatin Demonstrates Sustained Efficacy, Tolerability and LDL-C Target Attainment Over 52 Weeks

Wokingham, England, April 28, 2010 (ots/PRNewswire) - New long-term phase III data published today in Atherosclerosis demonstrates that, of patients with primary hypercholesterolaemia or combined dyslipidaemia who received 4mg of pitavastatin, 74% and 73.5% achieved NCEP* and EAS* low-density lipoprotein ...

Helsinn Healthcare SA

Helsinn and Vifor Pharma sign new contract for Gelclair in Switzerland

Lugano (ots) - New therapeutic option for the management of painful symptoms of oral mucositis in the oncology setting soon available for Swiss patients Helsinn, the pharmaceutical group based in Lugano, and Vifor Pharma, are pleased to announce that a Distribution & Licensing Agreement for Helsinn's product Gelclair in Switzerland has been signed recently. ...

Biodiversity Institute of Ontario - University of Guelph

International Barcode of Life Project Gets Major Funding Boost in Lead-Up to Official Launch

Guelph, Canada, April 23, 2010 (ots/PRNewswire) - The International Barcode of Life (iBOL) Secretariat today announced major new funding for the world's largest biodiversity genomics project. Paul Hebert, iBOL Scientific Director, said that four Canadian agencies have made new commitments totaling $35 million, raising total investments by these funders to $80 ...

VimpelCom LTD

VimpelCom Ltd. Successfully Completes Exchange Offer for OJSC VimpelCom Shares and American Depositary Shares

Amsterdam, April 21, 2010 (ots/PRNewswire) - VimpelCom Ltd. today announces the final results of its Exchange Offer for all shares and American Depositary Shares ("ADSs") of OJSC "Vimpel-Communications" ("OJSC VimpelCom") . The U.S. Offer expired on 15 April 2010, and the Russian Offer expired yesterday at ...

Agendia B.V.

Agendia and Ferrer inCode Expand MammaPrint(R) Distribution Agreement to Latin America

HUNTINGTON BEACH, California and AMSTERDAM, April 20, 2010 (ots/PRNewswire) -- Agendia, a world leader in molecular cancer diagnostics, announced today it has closed an agreement with Ferrer inCode for the commercialization of Agendia's FDA-cleared breast cancer recurrence test MammaPrint in Latin America. For the successful commercialization of MammaPrint, ...

European Wind Energy Association (EWEA)

Wind: 50% of EU Electricity in 2050

Warsaw, Poland, April 20, 2010 (ots/PRNewswire) - Wind energy will meet 50% of the EU's electricity demand in 2050, top wind energy personalities told Europe's largest wind energy conference and exhibition. Topping the agenda at the opening day of the European Wind Energy Conference and Exhibition (EWEC 2010) in Warsaw was Europe's long-term energy supply. "2050 might seem like a long way off, but the decisions ...

Astellas Pharma Europe Limited

Urology and Transplantation Will Drive Future Growth as Astellas Begins Move into Oncology

London, April 20, 2010 (ots/PRNewswire) - Today, on the fifth anniversary since its formation, Astellas Pharma Europe has confirmed that it will continue its emphasis on transplantation and urology while moving towards a new vision to build a strong presence in oncology. Astellas has shown robust growth since its creation, expanding its reach into new therapeutic ...

Stallergenes

Stallergenes: Positive Results for Oralair(R) Phase III Trial in the USA

Antony, France, April 19, 2010 (ots/PRNewswire) - Stallergenes S.A. today announced the first results of a phase III clinical trial (VO61.08) conducted in the USA on its sublingual grass pollen immunotherapy tablet, Oralair(R). This phase III study is the first clinical study in the USA to be conducted by Stallergenes as part of the Oralair(R) ...

Ivar Jacobson International

Ivar Jacobson International Announces New Version of EssWork

Stockholm, Sweden, April 19, 2010 (ots/PRNewswire) - Ivar Jacobson International today is releasing a new version of EssWork which provides a "smart" framework for developing, browsing and executing software development practices. New features in EssWork 3.0 enhance and simplify an organization's ability to roll-out large-scale agile software development by giving software teams process guidelines that efficiently ...

Biosign Technologies Inc.

Biosign Signs Master Distribution Agreement With DLF Solutions Inc. for Exclusive Rights in the Canadian Market

Toronto, April 16, 2010 (ots/PRNewswire) - Biosign Technologies Inc. (CNSX: BIO) ("Biosign" or the "Company"), and DLF Solutions Inc. (DLF), today announced they have signed a binding Heads of Agreement to enter into a Master Distribution Agreement to distribute Biosign products in Canada through DLF Solutions ...

WBR & FinRoad

TradeTech is Now Also Online With TradeTechOnline.com and Will Benefit From a Strong Partnership With FinRoad

London, April 16, 2010 (ots/PRNewswire) - Over 2000 senior traders from buy and sell side firms are gathering at the 10th annual TradeTech 2010 conference and expo on the 20th - 22nd April 2010 in London. This year, organizers of the TradeTech event decided to strengthen the effectiveness of the conference by ...

Bank of America Corporation

Bank of America Earns US$3.2 Billion in First Quarter

Charlotte, April 16, 2010 (ots/PRNewswire) - Bank of America Corporation today reported first-quarter 2010 net income of US$3.2 billion compared with a net loss of US$194 million in the fourth quarter and net income of US$4.2 billion a year earlier. After preferred dividends, the company earned US$0.28 per diluted share in the first quarter, up from a loss of US$0.60 per share in the fourth quarter and earnings of ...

The European Health Technology Institute for Socio-Economic Research (EHTI)

Italian Survey Shows Centralised Purchasing of Medical Devices Does not Reduce Price; Medical Devices Often Undervalued as Analyses Focus Only on Short-term Financial and Economic Aspects

Rome, April 16, 2010 (ots/PRNewswire) - Centralised purchasing of medical devices does not reduce prices and medical devices are often undervalued as analyses focus only on the short-term financial and economic perspectives. This was the core message that was presented by Prof Rosanna Tarricone, Executive ...

VimpelCom LTD

VimpelCom Ltd. Announces Results of U.S. Exchange Offer

Amsterdam, April 16, 2010 (ots/PRNewswire) - VimpelCom Ltd. today announces the results of the U.S. Offer for all shares and American Depositary Shares ("ADSs") of OJSC "Vimpel-Communications" ("OJSC VimpelCom") . The U.S. Offer expired yesterday at 5:00 pm, New York City time. A total of 308,309,375 ADSs (representing 15,415,468 shares) were validly tendered and not withdrawn in the U.S. Offer. It is expected that ...

Stallergenes

STALLERGENES : 1st Quarter 2010 : Sustained 13% Growth

Antony, France, April 15, 2010 (ots/PRNewswire) - EURm 2009 09/08 2010 10/09 EURm %Sales Var.% EURm %Sales Var.% Southern Europe 41.8 74 10 46.9 74 12 (1) Other EU countries 12.7 23 36 14.6 23 15 Other markets 1.7 3 0 1.8 3 8 SLIT 47.2 84 16 55.0 87 ...

Bayer HealthCare

Growing Threat From Potentially Lethal Diseases Highlighted at Meeting of Global Experts

New York, April 15, 2010 (ots/PRNewswire) - As experts from around the world met in New York this week they discussed the need for greater understanding of the threat posed by ticks, fleas and sand flies. Leading scientists called on veterinarians and dog-owners around the world to take action to protect dogs and humans from potentially lethal diseases. ...

WISeKey SA

WISeKey announces a Joint Venture with I-Teco to establish WISeKey Russia to provide eSecurity and Trusted Cloud Computing services